These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 7210701

  • 1. Metabolic fate of nicardipine hydrochloride, a new vasodilator, by various species in vitro.
    Higuchi S, Shiobara Y.
    Xenobiotica; 1980 Dec; 10(12):889-96. PubMed ID: 7210701
    [Abstract] [Full Text] [Related]

  • 2. Comparative pharmacokinetics of nicardipine hydrochloride, a new vasodilator, in various species.
    Higuchi S, Shiobara Y.
    Xenobiotica; 1980 Jun; 10(6):447-54. PubMed ID: 7426117
    [Abstract] [Full Text] [Related]

  • 3. Application of the stable isotope technique to the elucidation of the saturation phenomenon of nicardipine hydrochloride metabolizing enzyme activity in dogs.
    Higuchi S, Shiobara Y.
    Biomed Mass Spectrom; 1980 Aug; 7(8):339-44. PubMed ID: 7459425
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Metabolism of barnidipine hydrochloride, a potent calcium antagonist, in rat and dog.
    Teramura T, Tokunaga T, Matsumoto H, Watanabe T, Higuchi S.
    Xenobiotica; 1996 Feb; 26(2):177-87. PubMed ID: 8868001
    [Abstract] [Full Text] [Related]

  • 6. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS, Hatch HL, Kosea F, Nguyen HT, Choo EF, McClure KF, Taylor TJ, Henne KR, Kuperman AV, Dombroski MA, Letavic MA.
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [Abstract] [Full Text] [Related]

  • 7. Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor.
    Lin JH, Chiba M, Balani SK, Chen IW, Kwei GY, Vastag KJ, Nishime JA.
    Drug Metab Dispos; 1996 Oct; 24(10):1111-20. PubMed ID: 8894513
    [Abstract] [Full Text] [Related]

  • 8. Specific determination of plasma nicardipine hydrochloride levels by gas chromatography-mass spectrometry.
    Higuchi S, Kawamura S.
    J Chromatogr; 1981 May 08; 223(2):341-9. PubMed ID: 7251788
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cardiovascular pharmacology of nicardipine in animals.
    Takenaka T, Asano M, Shiono K, Shibasaki M, Inagaki O.
    Br J Clin Pharmacol; 1985 May 08; 20 Suppl 1(Suppl 1):7S-22S. PubMed ID: 4027153
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cytochrome P450-dependent drug oxidation activities in liver microsomes of various animal species including rats, guinea pigs, dogs, monkeys, and humans.
    Shimada T, Mimura M, Inoue K, Nakamura S, Oda H, Ohmori S, Yamazaki H.
    Arch Toxicol; 1997 May 08; 71(6):401-8. PubMed ID: 9195021
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacokinetic studies on nicardipine hydrochloride, a new vasodilator, after repeated administration to rats, dogs and humans.
    Higuchi S, Sasaki H, Seki T.
    Xenobiotica; 1980 Dec 08; 10(12):897-903. PubMed ID: 7210702
    [Abstract] [Full Text] [Related]

  • 17. Effects of nicardipine, a new dihydropyridine vasodilator, on coronary circulation and ischemia-induced conduction delay in dogs.
    Nakaya H, Kanno M.
    Arzneimittelforschung; 1982 Dec 08; 32(6):626-9. PubMed ID: 7202368
    [Abstract] [Full Text] [Related]

  • 18. Species and organ differences in first-pass metabolism of the ester prodrug L-751,164 in dogs and monkeys. In vivo and in vitro studies.
    Prueksaritanont T, Gorham LM, Ellis JD, Fernandez-Metzler C, Deluna P, Gehret JR, Strong KL, Hochman JH, Askew BC, Duggan ME, Gilbert JD, Lin JH, Vyas KP.
    Drug Metab Dispos; 1996 Nov 08; 24(11):1263-71. PubMed ID: 8937862
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate. 3rd communication: plasma concentrations of the unchanged drug and its deethylated metabolite in rats, dogs and monkeys.
    Nakamura A, Hirota T, Sugihara K, Morino A.
    Arzneimittelforschung; 1997 Feb 08; 47(2):169-74. PubMed ID: 9079236
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.